SCHEMBL352981

SCHEMBL352981

CN(O)C(=O)c1ccno1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.45
HSD17B10 Q99714 3/20 0.45
KDM4E B2RXH2 2/20 0.45
NPC1 O15118 2/20 0.45
ALDH1A1 P00352 2/20 0.45
MAPT P10636 2/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
KMT2A Q03164 3/20 0.42
LMNA P02545 2/20 0.40
MEN1 O00255 2/20 0.40
GAA P10253 4/20 0.40
GFER P55789 3/20 0.40
RORC P51449 2/20 0.39
DPP4 P27487 1/20 0.39
DPP9 Q86TI2 1/20 0.39
DPP7 Q9UHL4 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CHRNA4 P43681 2/20 0.38
CHRNB2 P17787 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7542962 0.86 HPGD (0.46) HPGDHSD17B10KDM4ENPC1ALDH1A1
SCHEMBL14309146 0.79 HPGD (0.45) HPGDHSD17B10KDM4ENPC1ALDH1A1
SCHEMBL12510831 0.79 HDAC4 (0.43) HPGDHSD17B10KDM4ENPC1ALDH1A1
SCHEMBL12262039 0.79 KMT2A (0.43) HPGDHSD17B10KDM4ENPC1ALDH1A1
SCHEMBL6050298 0.79 HPGD (0.48) HPGDHSD17B10KDM4ENPC1ALDH1A1
SCHEMBL12086365 0.77 ALDH1A1 (0.42) HPGDHSD17B10KDM4ENPC1ALDH1A1
SCHEMBL12084055 0.77 KMT2A (0.41) HPGDHSD17B10KDM4ENPC1ALDH1A1
SCHEMBL12989066 0.77 KMT2A (0.41) HPGDHSD17B10KDM4ENPC1ALDH1A1
SCHEMBL18426326 0.77 DPP4 (0.54) HPGDHSD17B10KDM4ENPC1ALDH1A1
SCHEMBL27520450 0.73 KMT2A (0.47) HSD17B10ALDH1A1MAPTKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148380-B2 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds CRESTONE, INC. (US) 2012-04-03 US disclosed
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds NAAA, AADAC, RPSA HPGD 1814/4885HSD17B10 3778/4885KDM4E 1862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.